Plain Votes

U.S. Senate · 119th Congress · S. 1414

Expedited Access to Biosimilars Act

A bill to amend the Public Health Service Act to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy.

Follow

Log in to follow this bill and get an email when there’s a new vote (premium).

Sponsor
Rand PaulR-KY
Introduced
April 10, 2025, in the Senate
Issue areas
Policy area
Health (from the Congressional Research Service)
Full text and actions
congress.gov

Votes on this bill (0)

Neither the House nor the Senate has held a roll-call vote on this bill.

Cosponsors (2)

1 Democrat, 1 Republican. Each member is shown with the party they were counted with on the day they signed on. How we count these

Signed on later